Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

At 26, most people are juggling rent, careers, and group chats, not life-or-death medical decisions. So when a young woman ...

A multitargeted T-cell therapy produced encouraging activity in a preliminary study of patients with pancreatic cancer, ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

A small group of patients with treatment-refractory, HER2-positive metastatic colorectal cancer achieved a remarkable response with a common targeted therapy regimen used to treat HER2-positive breast ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

MUSCAT: The Royal Hospital succeeded in localising molecular tests for colorectal cancer (KRAS, NRAS, BRAF) as part of ...

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...